Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Drugs for the control of epilepsy |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Drugs used in status epilepticus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 125mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 40mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 5%(1gm/100mL) intravenous |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 5%(2gm/100mL) intravenous |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 5%(4gm/100mL) intravenous |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 80mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 100mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 10gm/500mL intravenous |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 10gm/1000mL intravenous |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate 12.5%(1mEq/ml) injection 8ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Product containing phenacemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Brivaracetam (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Anticonvulsant and antiParkinsonian drug poisoning |
Causative agent (attribute) |
False |
Anticonvulsant |
Inferred relationship |
Some |
1 |
Anticonvulsant or antiparkinsonian drug poisoning NOS |
Causative agent (attribute) |
False |
Anticonvulsant |
Inferred relationship |
Some |
|
Stiripentol (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Rufinamide (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Hydantoin derivative anticonvulsant (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Lacosamide |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Anticonvulsant therapy |
Direct substance |
False |
Anticonvulsant |
Inferred relationship |
Some |
1 |
Allergy to anticonvulsant |
Causative agent (attribute) |
False |
Anticonvulsant |
Inferred relationship |
Some |
1 |
Eslicarbazepine |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Accidental poisoning caused by anticonvulsant |
Causative agent (attribute) |
False |
Anticonvulsant |
Inferred relationship |
Some |
1 |
Retigabine |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Perampanel |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Pheneturide (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Tiagabine hydrochloride (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Tiagabine hydrochloride monohydrate (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Gabapentin enacarbil |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Valpromide |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Valproate |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Eslicarbazepine acetate |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Free carbamazepine (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Aminoglutethimide (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Anticonvulsant drug-induced osteomalacia |
Causative agent (attribute) |
True |
Anticonvulsant |
Inferred relationship |
Some |
1 |
Exposure to anticonvulsant (event) |
Causative agent (attribute) |
True |
Anticonvulsant |
Inferred relationship |
Some |
1 |
Cenobamate |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Pancytopenia caused by anticonvulsant |
Causative agent (attribute) |
True |
Anticonvulsant |
Inferred relationship |
Some |
6 |
Neonatal disorder caused by anticonvulsant via breast milk |
Causative agent (attribute) |
True |
Anticonvulsant |
Inferred relationship |
Some |
1 |
Magnesium sulfate anhydrous |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate heptahydrate (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Magnesium sulfate trihydrate (substance) |
Is a |
True |
Anticonvulsant |
Inferred relationship |
Some |
|
Fetal disorder caused by anticonvulsant via placental transfer |
Causative agent (attribute) |
True |
Anticonvulsant |
Inferred relationship |
Some |
1 |